AbCellera

AbCellera Biologics Inc., commonly referred to as AbCellera, is a leading biotechnology company headquartered in California. Specialising in pharmaceutical preparation manufacturing, the firm focuses on the discovery and development of therapeutic antibodies. Since its founding in 2012, AbCellera has established itself as a pioneer in harnessing AI-driven technologies to accelerate drug discovery processes.

The company’s core offerings include antibody discovery platforms that enable rapid identification of potent therapeutic candidates, making them a notable player in the biotech industry. With a strong presence across North America and collaborations with major pharmaceutical firms, AbCellera has achieved significant milestones in advancing personalised medicine and immunotherapy. Its innovative approach and strategic partnerships position it as a key contributor to modern pharmaceutical development.